Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zomnir joins Hard Candy

This article was originally published in The Rose Sheet

Executive Summary

Urban Decay Creative Director Wende Zomnir appointed creative director of sister brand Hard Candy. Exec is charged with returning the brand to "prestige teen" positioning under new parent The Falic Group, firm announces. Zomnir, who will remain creative director of Urban Decay, will work to revive the brand with more functional, "eye-catching" packaging and lower price points. Hard Candy and Urban Decay were once niche rivals in the cosmetics industry before both were acquired by LVMH. Under luxury goods manufacturer's ownership, Hard Candy struggled to define its position in the market and registered revenue declines, while Urban Decay turned in solid performance (1"The Rose Sheet" Dec. 23, 2002, p. 6). Both brands were purchased by Duty Free Americas owner, The Falic Group, in December (2"The Rose Sheet" Feb. 3, 2003, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011148

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel